Clinical Trial Update: Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 pilot study evaluating dose-dense chemotherapy plus bevacizumab for high-risk lymph node-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Chap, Linnea I., M.D. | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN